logologo
QuantliQuantli

Candel Therapeutics Inc

CADL

NASDAQ

Biotechnology

$11.72

USD

-0.08 (-0.68%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $864.59M

Volume 2.1M

Price Target

$22.00$22.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $22.00 and a min estimate of $22.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$22.00

-$3.5 vs prior

Implied Upside

+87.7%

-29.9% vs prior

Analyst Covering

1

-1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

33%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Stephen Willey

Stifel

Buy

Initiated

4 weeks ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BMEA

Biomea Fusion Inc

$1.32

+3.1%

XGN

Exagen Inc

$6.66

+1.2%

COYA

Coya Therapeutics Inc

$4.79

+2.6%

GANX

Gain Therapeutics Inc

$2.12

-2.1%

ANIX

Anixa Biosciences Inc

$3.18

-0.6%

INO

Inovio Pharmaceuticals Inc

$1.09

+21.1%

FBIO

Fortress Biotech Inc

$2.93

-1.7%